Waycross Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511K Hold
6,000
0.05% 46
2025
Q4
$474K Hold
6,000
0.04% 66
2025
Q3
$480K Hold
6,000
0.04% 68
2025
Q2
$545K Hold
6,000
0.05% 63
2025
Q1
$562K Hold
6,000
0.06% 56
2024
Q4
$545K Hold
6,000
0.07% 55
2024
Q3
$623K Hold
6,000
0.09% 56
2024
Q2
$582K Hold
6,000
0.09% 63
2024
Q1
$540K Hold
6,000
0.09% 64
2023
Q4
$478K Hold
6,000
0.09% 73
2023
Q3
$427K Hold
6,000
0.09% 82
2023
Q2
$462K Hold
6,000
0.1% 84
2023
Q1
$451K Hold
6,000
0.13% 77
2022
Q4
$473K Hold
6,000
0.17% 74
2022
Q3
$421K Hold
6,000
0.28% 80
2022
Q2
$481K Hold
6,000
0.32% 69
2022
Q1
$455K Hold
6,000
0.27% 73
2021
Q4
$512K Hold
6,000
0.29% 75
2021
Q3
$453K Hold
6,000
0.29% 77
2021
Q2
$488K Hold
6,000
0.26% 68
2021
Q1
$473K Hold
6,000
0.26% 72
2020
Q4
$513K Buy
+6,000
New +$496K 0.32% 68

Other funds holding CL

Waycross Partners's CL Position: Q1 2026 in Review

Waycross Partners held its Colgate-Palmolive (CL) position steady in Q1 2026 at 6,000 shares worth $511K. The position accounts for 0.05% of the portfolio, ranked #46.

Waycross Partners first reported a position in CL in Q4 2020 and has held it in 22 quarters since. The position peaked at $623K in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Waycross Partners held 6,000 shares of Colgate-Palmolive worth $511K as of Q1 2026.
  • Waycross Partners left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.05% of Waycross Partners's portfolio in Q1 2026, its #46 holding.
  • Waycross Partners first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 22 quarters since.
  • Waycross Partners's Colgate-Palmolive position peaked at $623K in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Waycross Partners's 13F filing for Q1 2026, filed 7 May 2026.